Vale-Fernandes, E.; Barreiro, M.; Leal, C.; Macedo, R.Z.; Tomé, A.; Monteiro, M.P.
Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome. Biomedicines 2023, 11, 3150.
https://doi.org/10.3390/biomedicines11123150
AMA Style
Vale-Fernandes E, Barreiro M, Leal C, Macedo RZ, Tomé A, Monteiro MP.
Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome. Biomedicines. 2023; 11(12):3150.
https://doi.org/10.3390/biomedicines11123150
Chicago/Turabian Style
Vale-Fernandes, EmÃdio, Márcia Barreiro, Carla Leal, Rosa Zulmira Macedo, António Tomé, and Mariana P. Monteiro.
2023. "Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome" Biomedicines 11, no. 12: 3150.
https://doi.org/10.3390/biomedicines11123150
APA Style
Vale-Fernandes, E., Barreiro, M., Leal, C., Macedo, R. Z., Tomé, A., & Monteiro, M. P.
(2023). Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome. Biomedicines, 11(12), 3150.
https://doi.org/10.3390/biomedicines11123150
